Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Ceraxa (nanoliposomal ceramide)
i
Other names:
KN-001, KN 001, KN-01, CNL
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Keystone Nano
Drug class:
Apoptosis inducer, PP2A activator
Related drugs:
‹
BCN057 (1)
TGX-221 (1)
RITA (0)
EPC2407 (0)
iMX-110 (0)
ST-001 nanoFenretinide (0)
SAR650984 SC (0)
Andes-1537 (0)
CB1089 (0)
Utt-B (0)
BCN057 (1)
TGX-221 (1)
RITA (0)
EPC2407 (0)
iMX-110 (0)
ST-001 nanoFenretinide (0)
SAR650984 SC (0)
Andes-1537 (0)
CB1089 (0)
Utt-B (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF T1799A
Breast Cancer
BRAF T1799A
Breast Cancer
sorafenib + nanoliposomal ceramide
Sensitive: D – Preclinical
sorafenib + nanoliposomal ceramide
Sensitive
:
D
sorafenib + nanoliposomal ceramide
Sensitive: D – Preclinical
sorafenib + nanoliposomal ceramide
Sensitive
:
D
BRAF T1799A
Melanoma
BRAF T1799A
Melanoma
sorafenib + nanoliposomal ceramide
Sensitive: D – Preclinical
sorafenib + nanoliposomal ceramide
Sensitive
:
D
sorafenib + nanoliposomal ceramide
Sensitive: D – Preclinical
sorafenib + nanoliposomal ceramide
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login